Robins Chad M

CEO And Chairman

1 company

Good

Trades Analyzed

12M Win Rate

70.4%

Avg 3M Return

+10.3%

Avg 12M Return

+19.8%

Robins Chad M is a CEO And Chairman at Adaptive Biotechnologies Corporation. Recent SEC Form 4 filings include 0 buys and 24 sells.

Estimated insider holdings value: $38.8M based on current market prices.

Holdings by Company

ADPTApr 8, 2026

Current Shares2.18M

Value$38.78M

Net Activity-2,991,825

Bought: 0Sold: 2.99M

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 8, 2026	ADPT Adaptive Biotechnologies Corporation	CEO And Chairman	Sell	120,595	$14.65	$1,766,839.09	-2.7%	-	-
Mar 11, 2026	ADPT Adaptive Biotechnologies Corporation	CEO And Chairman	Sell	470,167	$13.17	$6,192,099.39	-8.7%	+22.1%	-
Jan 5, 2026	ADPT Adaptive Biotechnologies Corp	CEO And Chairman	Sell	124,998	$15.59	$1,948,718.82	-4.6%	-12.9%	-
Dec 1, 2025	ADPT Adaptive Biotechnologies Corp	CEO And Chairman	Sell	160,734	$19.10	$3,070,746.60	-2.8%	-14.5%	-
Nov 12, 2025	ADPT Adaptive Biotechnologies Corp	CEO And Chairman	Sell	89,265	$14.73	$1,315,179.62	-1.0%	+7.9%	-
Mar 6, 2025	ADPT Adaptive Biotechnologies Corp	CEO And Chairman	Sell	219,569	$7.29	$1,600,416.95	-2.5%	+28.4%	+91.2%
Feb 20, 2025	ADPT Adaptive Biotechnologies Corp	CEO And Chairman	Sale+OE	285,187	$8.45	$2,410,699.88	-5.2%	+9.1%	+82.5%
Feb 18, 2025	ADPT Adaptive Biotechnologies Corp	CEO And Chairman	Sale+OE	470,368	$8.47	$3,985,753.94	-5.7%	+11.2%	+91.9%
Mar 5, 2024	ADPT Adaptive Biotechnologies Corp	CEO And Chairman	Sell	48,673	$3.43	$167,007.18	-0.9%	-12.4%	+112.4%
Mar 9, 2022	ADPT Adaptive Biotechnologies Corp	CEO And Chairman	Sale+OE	44,445	$11.80	$524,351.55	-0.6%	-45.9%	-35.9%